Original paper
Endocrine disruptors and the future of toxicology testing — lessons from CLARITY–BPA
Abstract
Five years ago, an ambitious collaboration, the Consortium Linking Academic and Regulatory Insights on Toxicity of BPA (CLARITY–BPA; henceforth CLARITY), was launched by three US agencies. The goal was to provide a definitive evaluation of bisphenol A (BPA) and explain disparities between traditional regulatory studies and findings from independent investigators. BPA or vehicle-treated rats from an FDA facility were used in a guideline study and...
Paper Details
Title
Endocrine disruptors and the future of toxicology testing — lessons from CLARITY–BPA
Published Date
Mar 6, 2019
Journal
Volume
15
Issue
6
Pages
366 - 374